Rumored Buzz on Hemgenix
Range of suitable people: CDEC talked over the uncertainty in the number of people with reasonably critical to intense hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical authorities consulted by CADTH indicated that some sufferers who're categorized as getting mild or reasonable ailment could have a significant bleeding phenoty